{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:46Z","timestamp":1786997506408,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T00:00:00Z","timestamp":1394409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.thromres.2014.03.009","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T03:30:47Z","timestamp":1394163047000},"page":"1016-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Safety and efficacy of edoxaban in patients undergoing hip fracture surgery"],"prefix":"10.1016","volume":"133","author":[{"given":"Takeshi","family":"Fuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohko","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.03.009_bb0005","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.03.009_bb0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1253\/circj.CJ-88-0010","article-title":"Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009)","volume":"75","author":"JCS Joint Working Group","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.thromres.2014.03.009_bb0015","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.03.009_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/clc.4960240207","article-title":"Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research","volume":"24","author":"Nakamura","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.thromres.2014.03.009_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s003800200036","article-title":"Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure","volume":"17","author":"Ota","year":"2002","journal-title":"Heart Vessels"},{"key":"10.1016\/j.thromres.2014.03.009_bb0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00776-008-1264-0","article-title":"Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin","volume":"13","author":"Fuji","year":"2008","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.thromres.2014.03.009_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00264-007-0360-7","article-title":"Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients","volume":"32","author":"Fuji","year":"2008","journal-title":"Int Orthop"},{"key":"10.1016\/j.thromres.2014.03.009_bb0040","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s11999-010-1306-8","article-title":"Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery","volume":"468","author":"Wilke","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.thromres.2014.03.009_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00068-002-1176-1","article-title":"Compliance with self-administration of heparin injections in outpatients","volume":"28","author":"Spahn","year":"2002","journal-title":"Eur J Trauma"},{"key":"10.1016\/j.thromres.2014.03.009_bb0050","doi-asserted-by":"crossref","first-page":"358-6","DOI":"10.1002\/cpdd.53","article-title":"Bioavailability and safety of the factor Xa inhibitor edoxaban and the effects of quinidine in healthy subjects","volume":"2","author":"Matsushima","year":"2013","journal-title":"Clin Pharm Drug Dev"},{"key":"10.1016\/j.thromres.2014.03.009_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0091270009351883","article-title":"Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers","volume":"50","author":"Ogata","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2014.03.009_bb0060","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/j.1538-7836.2010.04021.x","article-title":"A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty","volume":"8","author":"Fuji","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.03.009_bb0065","first-page":"2098","article-title":"Edoxaban in patients undergoing total hip arthroplasty: a phase IIb dose-finding study","volume":"114","author":"Fuji","year":"2009","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.thromres.2014.03.009_bb0070","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1160\/TH10-02-0142","article-title":"Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose\u2013response study","volume":"104","author":"Raskob","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.03.009_bb0115","series-title":"Clexane\u00ae for Subcutaneous Injection Kit 2000IU [Package Insert (Ver. 5), in Japanese]","year":"2010"},{"key":"10.1016\/j.thromres.2014.03.009_bb0085","first-page":"A20","article-title":"Edoxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial","volume":"37","author":"Fuji","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2014.03.009_bb0090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.3320.3320","article-title":"Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V trial","volume":"116","author":"Fuji","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.03.009_bb0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood.V118.21.208.208","article-title":"Edoxaban versus enoxaparin for the prevention of venous thromboembolism: pooled analysis of venous thromboembolism and bleeding from STARS E-3 and STARS J-V","volume":"118","author":"Fuji","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.03.009_bb0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH11-08-0566","article-title":"Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation","volume":"107","author":"Salazar","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.03.009_bb0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1592\/phco.21.1.108.34436","article-title":"Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity","volume":"21","author":"Carlson","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2014.03.009_bb0110","series-title":"Lixiana [package insert]","year":"2011"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T22:52:44Z","timestamp":1597531964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0049384814001340"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.03.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of edoxaban in patients undergoing hip fracture surgery","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}